Authors
Latest:
Private-payer Costs for Employees with Treatment-resistant DepressionIndividuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Latest:
A Primer on the Newly-Approved OTC Asthma InhalerSome may remember the old formulation of OTC Primatene Mist that was taken off the market in 2011 because it contained chlorofluorocarbon (CFC) propellants, which are known to deplete the ozone layer.
Latest:
How to Discuss Pharmacogenetics with Your PatientsAs the medical community works toward fully embracing precision medicine, pharmacogenetics is anticipated to be the foundation of this important movement in personalized medicine.
Latest:
A Word on HeartburnMany OTC options are currently available to relieve heartburn. This article will help patients find the right medication for them.
Latest:
Recent Law Addresses the Opioid CrisisEliminating Kickbacks in Recovery Act of 2018 Is an attempt to eliminate ‘patient brokering’.
Latest:
Toxicology: Is It Influenced by Pharmacogenetics?Numerous, important differences exist in the ways that humans metabolize xenobiotics. These interindividual differences can directly affect the efficacy and toxicity of drugs and other foreign substances.
Latest:
Temperature-Sensitive MedicationsPharmacists can improve patient adherence by providing education on the importance of keeping medications within proper temperature range.
Latest:
New Treatments for Cancer, Migraines Highlight Specialty Pipeline in 2018In 2018, watch for novel cancer drugs and several new orphan drugs to affect the market.
Latest:
Identification of Drug Therapy Opportunities with Oral ChemotherapyThere is a need for continued adverse event management for patients receiving oral chemotherapy due to the high incidence of adverse events and discontinuation rates. Pharmacists play a unique role in helping patients manage complicated dosing regimens, drug interactions, and adverse event profiles of oral chemotherapy.
Latest:
Pharmacist Rounds: Hypertensive Crisis in the Health SystemUnderstanding the difference between hypertensive urgency and hypertensive emergency is essential to initiating patient appropriate treatment in a timely. This article reviews targeted therapies for both.
Latest:
Disability Income Insurance: Why It's Important for PharmacistsFew pharmacists opt to protect their income through disability insurance.
Latest:
Trending News: Call for Increased Awareness, Education of Fulminant Myocarditis Among Health ProvidersTop news of the day from across the health care landscape.
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Latest:
Comparison of Pharmacists and Primary Care Providers as ImmunizersPharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.
Latest:
New Tools for a New Normal in PharmacyPharmacists need new tools to reduce administrative burden and provide the best care to patients.
Latest:
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Latest:
How Integrated Health Care Delivery Networks Collaborate to Optimize Specialty Pharmacy CareAs the number of specialty drugs has grown in the past decade, regional health systems and academic medical centers have stepped up to assert the power of integration and coordinated care by establishing and expanding their own specialty pharmacies.
Latest:
Adherence and Compliance: You Say Tomato, I Say ToMAHtoWhatever it's called, failure to take medication as prescribed is widespread, but pharmacists can help.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
Latest:
Exercise: Another Potential Option for Substance Abuse DisorderExercise improves psychological, behavioral, neurobiological, and overall health of patients.
Latest:
Data Suggest Combination Abilities of OP-1250, Palbociclib for Breast Cancer at SABCSOP-1250 and palbociclib showed “enhanced suppression of tumor growth” in preclinical mouse model studies, according to expert who presented his findings in a poster at the San Antonio Breast Cancer Symposium 2022.
Latest:
AACR Progress Report Highlights New Drugs Along With Disparities, Challenges of Obesity, Aging PopulationThe annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances.
Latest:
Biologic Management for IBDWith increased specialty medication prescribing, associated costs, and the interest of health systems to establish specialty pharmacies for improved patient care, it is vital to define the pharmacist's role within the patient's health care team.
Latest:
PARP Inhibitors: A Novel Approach to Treating Ovarian CancerPARP inhibitors are novel therapies with indication focused on ovarian cancer; however, new agents are being studied for other cancers as well.
